No Detail Found!

The Evolving Therapeutic Landscape of Nanoscale Cancer Drug Delivery Systems: Future Perspectives

Author(s)
NAFEESA QUDSIA HANIF Pakistan Council of Scientific and Industrial Research (PCSIR), Islamabad, Pakistan
BUSHRA ARSHAD Pakistan Council of Scientific and Industrial Research (PCSIR), Islamabad, Pakistan
ANILA FARIQ Pakistan Council of Scientific and Industrial Research (PCSIR), Islamabad, Pakistan
SYED HUSSAIN IMAM ABIDI Pakistan Council of Scientific and Industrial Research (PCSIR), Islamabad, Pakistan
SOHAIL AMEER MARWAT Pakistan Council of Scientific and Industrial Research (PCSIR), Islamabad, Pakistan
ANEELA FATIMA Pakistan Council of Scientific and Industrial Research (PCSIR), Islamabad, Pakistan
Abstract
Cancer is one of the main causes of deaths in the world. Conventional cancer therapeutic approaches such as chemo- and radiotherapy have burdened the cancer patients with arduous physical and psychological challenges. Moreover, in case of onset of this disease, huge amount is required against the medications (chemotherapy and radiotherapy). It is estimated that annually, the increasing cancer disease incidence rate is alarming. In developed countries, the health support is given by the nation. Therefore, the health managements in the developed nations are over-burdened due to heavy expanses against expansive cancer therapy treatments. Interestingly, tumor treatments have undergone a comprehensive and remarkable transformation. Scientists are working for finding out the effective possible treatments against various types of cancer. In this backdrop, in this review, we discussed recently developed cancer drugs targeting/ delivery techniques. It will provide a detailed explanation of each method, addressing their status of development, clinical challenges, and potential solutions. The aim is to assist clinicians and researchers in gaining a deeper insight of these diverse treatment options, enabling them to carry out effective treatment and advance their research more proficiently.
Publication Details
Page(s) 1-34
DOI DOI not available
Published Journal: Journal of Bioresource Management, Volume: 12, Issue: 4, Year: 2025

Request the full text from PASTIC

Keywords
nutraceutical, Niosomes, tumor, API, chemotherapy.
References
Akbarzadeh I,Shayan M,Bourbourm M,Moghtaderi M,Noorbazargan H,Eshrati Yeganeh F,Saffar S,Tahriri M .2021 .Preparation, optimization, and in-vitro evaluation of curcumin-loaded niosome@ calcium alginate nanocarrier as a new approach for breast cancer treatment. Biol, 10(2) : 1-27.
Akhter K,Ullah K,Talat R,Haider A,Khalid N,Ullah F,Ali S .2019 .Synthesis and characterization of cationic surfactants and their interactions with drug and metal complexes. Heliyon, 5(6) : 1-8.
Alajmi AA,Al Otaibi SG,Alzubidi AHA,Alanazi AAA,Abdullah SA,Alrbian AAM .2023 .Advancements in nanomedicine: Targeted drug delivery systems for cancer treatment. Intl J. of Health Sci., 7(1) : 3655-3682.
Ali MA,Aiman W,Shah SS,Hussain M .2021 .Kashyap R. Efficacy and safety of Pembrolizumab based therapies in triple-negative breast cancer: A systematic review of clinical trials. Critical Reviews in Oncol/ Hematol, 157 : 103-197.
Amin M,Seynhaeve ALB,Sharifi M,Falahati M,Ten Hagen TLM .2022 .Liposomal Drug Delivery Systems for Cancer Therapy: The Rotterdam Experience. , 14(10) : 2165.
Assikis VJ,Buzdar A .2002 .Recent advances in aromatase inhibitor therapy for breast cancer. , 29(3) : 120-128.
Barani M,Mirzaei M,Torkzadeh-Mahani M,Nematollahi MH .2018 .Lawsone-loaded Niosome and its antitumor activity in MCF-7 breast Cancer cell line: a Nano-herbal treatment for Cancer. , 26(1) : 11-17.
Beer TM,AJ TM .2014 .Enzalutamide in metastatic prostate cancer before chemotherapy. New England J Med, 371(5) : 424-433.
Bergsland E,Dickler MN .2004 .Maximizing the potential of bevacizumab in cancer treatment. The Oncol., 9(Suppl, 1 : 36-42.
Bhardwaj P,Tripathi P,Gupta R,Pandey S,Part A .2020 .Niosomes: A review on niosomal research in the last decade. J of Drug Deliver Sci and Technol, 101581 : .
Bonifazi M,Franchi M,Rossi M,Moja L,Zambelli A,Zambon A,Corrao G,La Vecchia C,Zocchetti C,Negri E .2013 .Trastuzumab-related cardiotoxicity in early breast cancer: a cohort study. Oncologist, 18(7) : 795-801.
Danaei M,Dehghankhold M,Ataei S,Hasanzadeh Davarani F,Javanmard R,Dokhani A,Khorasani S,Mozafari MR .2018 .Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems. , 18(2) : 57.
Darson J,Thirunellai Seshadri,Katariya R,Mohan K,Kamath M,Etyala MS,Chandrasekaran MA,G MA .2023 .Design development and optimisation of multifunctional Doxorubicin-loaded Indocynanine Green proniosomal gel derived niosomes for tumour management. Sci Rep., 13 : 1697.
Deininger MW,Druker BJ .2003 .Specific targeted therapy of chronic myelogenous leukemia with imatinib. Pharmacol Rev., 55(3) : 401-423.
Druker BJ,Tamura S,Buchdunger E .2001 ."Effects of a selective inhibitor of the BCRABL tyrosine kinase on the growth of BCR-ABL-positive cells. " Nature Med, 7(6) : 663-669.
El-Ela F IA,Gamal A,Elbanna HA,Tulbah HF,AS HF .2022 .In vitro and in vivo evaluation of the effectiveness and safety of amygdalin as a cancer therapy. Pharmaceut, 15(11) : 1306.
Fadaei MS,Fadaei MR,Kheirieh AE,Rahmanian-Devin P,Dabbaghi MM,Tavallaei KN,Shafaghi A,H A,Nokhodchi VB,Askari A,VR A .2024 .Niosome as a promising tool for increasing the effectiveness of anti-inflammatory compounds. EXCLI J, 23 : 212.
Fahmy SA,Ramzy A,Sawy AM,Nabil M,Gad MZ,El-Shazly M,Aboul-Soud MAM,Azzazy HM .2022 .Ozonated Olive Oil: Enhanced Cutaneous Delivery via Niosomal Nanovesicles for Melanoma Treatment. , 11 : 1318.
Fan D,Cao Y,Cao M,Wang Y,Cao Y,Gong T .2023 .Nanomedicine in cancer therapy. Signal Transduct Target Ther., 8(1) : 293.
Amandi Firouzi,Bahmanyar A,Dadashpour Z,M Z .2024 .Fabrication of magnetic niosomal platform for delivery of resveratrol: Potential anticancer activity against human pancreatic cancer Capan-1 cells. Cancer Cell Intl. , 24 : 46.
Fong PC,Boss D,Yap TA .2009 .Inhibition of poly (ADP-ribose) polymerase in tumors from BRCA mutation carriers. New England J Med, 361(2) : 123-134.
Gaikwad DS,Chougale RD,Patil KS,Disouza JI,Hajare AA .2023 .Design, development, and evaluation of docetaxel-loaded niosomes for the treatment of breast cancer. Future Journal of Pharm Sci., 9(1) : 43.
Galluzzi L,Senovilla L,Vitale I,Michels J,Martins I,Kepp O,Kroemer G .2012 .Molecular mechanisms of cisplatin resistance. Oncogene, 31(15) : 1869-1883.
Georg V .2020 .The Mechanism of Action of Cyclophosphamide and Its Consequences for the Development of a New Generation of Oxazaphosphorine Cytostatics. Sci Pharm., 88(4) : 42.
Ghode PD,Shweta P,Ghode P .2021 .Niosomes as Modern Drug Carrier Systems: Concepts and Advancements. Int J Med Phar Sci., 11(2) : 1-8.
Hajizadeh MR,Maleki H,Barani M,Fahmidehkar MA,Mahmoodi M,Torkzadeh-Mahani M .2019 .. Res Pharm Sci., 14 : 448.
Hamimed S,Jabberi M,Chatti A .2022 .Nanotechnology in drug and gene delivery. Naunyn Schmiedebergs Arch Pharmacol., 395(7) : 769-787.
Hu C,Rhodes DG .2000 .Proniosomes: A novel drug carrier preparation. Intl J Pharm., 206(1-2) : 110-122.
Huang J,Ssentongo P,Sharma R .2023 .Editorial: Cancer burden, prevention and treatment in developing countries. Front Public Health, 10 : 1124473.
Jordan VC .2007 .New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer. Steroids, 72(13) : 829-842.
Jordan .2004 .Microtubules as a target for anticancer drugs. Nature Reviews Cancer, 4(4) : 253-265.
Judy E,Lopus M,Kishore N .2021 .Mechanistic insights into encapsulation and release of drugs in colloidal niosomal systems: Biophysical aspects. RSC Adv, 11(56) : 35110-35126.
Kantarjian HM,O'Brien S,Gattermann N .2006 .Decitabine improves survival in patients with acute myeloid leukemia. Cancer, 107(3) : 506-514.
Kaur S,Kumari A,Kumari Negi A,Galav V,Thakur S,Agrawal M,Sharma V .2021 .Nanotechnology based approaches in phage therapy: overcoming the pharmacological barriers. , 12 : 699054.
Kauslya A,Borawake PD,Shinde JV,Chavan RS .2021 .Niosomes: A Novel Carrier Drug Delivery System. J. Drug Delivery Ther, 11(1) : 162-70.
Kciuk M,Gielecińska A,Mujwar S,Kołat D,Kałuzińska-Kołat Ż,Celik I,Kontek R .2023 .Doxorubicin-An Agent with Multiple Mechanisms of Anticancer Activity. Cells, 12(4) : 659.
Khan MI,Madni A,Peltonen L .2016 .Development and in-vitro characterization of sorbitan monolaurate and poloxamer 184 based niosomes for oral delivery of diacerein. Eur J Pharm Sci., 95 : 88-95.
Khan R,R R .2016 .Niosomes: A Potential Tool for Novel Drug Delivery. Journal of Pharmaceutical Investigation, 46 : 195-204.
Kolate A,Baradia D,Patil S,Vhora I,Kore G,Misra A .2014 .PEG - A versatile conjugating ligand for drugs and drug delivery systems. J. of Controlled Release, 192 : 67-81.
Koshani R,Jafari SM .2019 .Ultrasound-assisted preparation of different nanocarriers loaded with food bioactive ingredients. Adv Colloid Interface Sci, 270 : 123-146.
Kumar V,Bansal V,Madhavan A,Kumar M,Sindhu R,Awasthi MK Saran S .2022 .Active pharmaceutical ingredient [API] chemicals: A critical review of current biotechnological approaches. Bioengineered, 13(2) : 4309-4327.
Kumbhar D,Wavikar P,Vavia P .2013 .Niosomal gel of lornoxicam for topical delivery: in vitro assessment and pharmacodynamic activity. AAPS Pharm Sci Tech., 14(3) : 1072-82.
Kusdemir BC,Kozgus Guldu O,Yurt Kilcar A,Medine EI .2023 .Preparation and in vitro investigation of prostate-specific membrane antigen targeted lycopene loaded niosomes on prostate cancer cells. Intl J of Pharm., 640 : 123013.
Lalam ZA,Tafvizi F,Naseh V,Salehipour M .2022 .Characterization and optimization of co-delivery farnesol-gingerol niosomal formulation to enhance anticancer activities against breast cancer cells. J Drug Delv Sci Technol., 72 : 103371.
Lasic DD .1998 .Novel applications of liposomes. Trends Biotechnol, 16(7) : 307-21.
Li S,Chen L,Fu Y .2023 .Nanotechnology-based ocular drug delivery systems: Recent advances and future prospects. J. Nanobiotechnol., 21(1) : 232.
Liga S,Paul C,Moacă EA,Péter F .2024 .Niosomes: Composition, Formulation Techniques, and Recent Progress as Delivery Systems in Cancer Therapy. Pharmaceutics, 16(2) : 223.
Liu G,Yang L,Chen G,Xu F,Yang F,Yu H,Li L,Dong X,Han J,Cao C,Qi J,Su J,Xu X,Li X,Li B .2021 .A Review on Drug Delivery System for Tumor Therapy. , 12 : 735446.
Lohumi A .2012 .A novel drug delivery system: Niosomes review. J. Drug Deliv. Ther., 2 : 130-134.
Longley DB,Harkin DP,Johnston PG .2003 ."5-Fluorouracil: mechanisms of action and clinical strategies.". Nature Rev. Cancer, 3(5) : 330-338.
Mahale NB,Mali PD,Walunj RG,Chaudhari DR,SR DR .2012 .Niosomes: Novel sustained release nonionic stable vesicular systems - An overview. Adv in Colloid and Interface Sci, 183 : 46-54.
Manosroi A,Chutoprapat R,Abe M,Manosroi J .2008 .Characteristics of niosomes prepared by supercritical carbon dioxide (scCO2) fluid. Int J Pharm., 352(1-2) : 248-55.
Marino P,Mininni M,Deiana G,Marino G,Divella R,Bochicchio I,Giuliano A,Lapadula S,Lettini AR,Sanseverino F .2024 .Healthy Lifestyle and Cancer Risk: Modifiable Risk Factors to Prevent Cancer. , 16(6) : Pp800.
Masoudi M,Gopalan R .2023 .Cancer stem cells in drug resistance and recurrence. , 15(2) : Pp542.
Maude SL,Laetsch TW,Buechner J .2018 .Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. New England J of Med, 378(5) : 439-448.
Mawazi SM,Ge Y,Widodo RT .2025 .Niosome Preparation Techniques and Structure-An Illustrated Review. , 17(1) : 67.
Moammeri A,Chegeni MM,Sahrayi H,Ghafelehbashi R,Memarzadeh F,Mansouri A,Akbarzadeh I,Abtahi MS,Hejabi F,Ren Q .2023 .Current advances in niosomes applications for drug delivery and cancer treatment. Mater, 23 : 100837.
Moghassemi S,Hadjizadeh A .2014 .Nano-niosomes as nanoscale drug delivery systems: an illustrated review. J Control Release, 185 : 22-36.
Mohanty R,Chowdhury CR,Arega S,Sen P,Ganguly P,Ganguly N .2019 .CAR T cell therapy: A new era for cancer treatment. Oncology reports, 42(6) : 2183-2195.
Muzzalupo R,Mazzotta E .2019 .Do niosomes have a place in the field of drug delivery? Expert Opinion Drug Deliv. , 16(11) : 1145-1147.
Mythili L,Ganesh C,Kayalvizhi R C .2019 .. Ocular Drug Delivery System - An update Review. Res J. Pharm and Tech., 12(5) : 2527-2538.
Newman DJ,Cragg GM . .Natural products as sources of new drugs over the last 25 years. J Nat Prod., 70(3) : 461-477.
Okafo SE,Ordu J I,Ofagbor G,Agbamu E .2023 .Evaluation of physicochemical, in vivo analgesic and antiinflammatory activities of Brachystegia eurycoma gum-based naproxen loaded niosomal gels. Ger J Pharm Biomater., 2(1) : 26-37.
Palumbo A,Rajkumar SV,Harousseau JL .2008 .Combined therapy with bortezomib and dexamethasone for multiple myeloma. New England J of Med, 359(6) : 654-664.
Pandey P,Pal R,Khadam VKR,Chawra HS,Singh RP .2024 .Advancement and Characteristics of Non-Ionic Surfactant Vesicles (Niosome) and their Application for Analgesics. Int. J. Pharm. Investig., 4(3) : 616-632.
Primavera R,Palumbo P,Celia C,Cinque B,Carata E,Carafa M,Paolino D,Cifone MG,Di Marzio MG .2018 .An insight of in vitro transport of PEGylated non-ionic surfactant vesicles (NSVs) across the intestinal polarized enterocyte monolayers. European J of Pharm and Biopharm, 127 : 432-42.
Raut DJ,Shirode DS,Deokar SS,Saoji VV,Rajput GD,Deore MR,Powar PV .2023 .Latin American Journal of Pharmacy: A Life Sci. , 42(3) : 347-354.
Saha U,De R,Das B .2023 .Interactions between loaded drugs and surfactant molecules in micellar drug delivery systems: A critical review. J of Mol. Liquids, 382 : 121906.
Salem HF,Kharshoum RM,Abou-Taleb HA,Farouk HO,Zaki RM .2021 .Fabrication and appraisal of simvastatin via tailored niosomal nanovesicles for transdermal delivery enhancement: In vitro and in vivo assessment. Pharmaceutics, 13(2) : 138.
Santucci C,Carioli G,Bertuccio P,Malvezzi M,Pastorino U,Boffetta P .2020 .Progress in cancer mortality, incidence, and survival: A global overview. Eur J. Cancer Prev, 29 : 367-81.
Shafiei G,Jafari-Gharabaghlou D,Farhoudi-Sefidan-Jadid M,Alizadeh E,Fathi M,Zarghami N .2023 .Targeted delivery of silibinin via magnetic niosomal nanoparticles: Potential application in treatment of colon cancer cells. Frontr in Pharmacol., 14 : 1174120.
Shahbazi R,Jafari-Gharabaghlou D,Mirjafary Z,Saeidian H,Zarghami N .2023 .Design and optimization of various formulations of PEGylated niosomal nanoparticles loaded with phytochemical agents: Potential anti-cancer effects against human lung cancer cells. Pharmacol Reports, 75(2) : 442-455.
Shrestha B,Tang L,Hood RL .2022 .Nanotechnology for Personalized Medicine. , 48 : Pp1.
Slamon DJ,Leyland-Jones B,Shak S .2001 .Use of chemotherapy plus trastuzumab (Herceptin) to treat women with HER2-positive breast cancer. New England J of Med, 344(11) : 783-792.
Iacob AT,Ababei-Bobu A,Chirliu OM,Lupascu FG,Vasincu IM,Apotrosoaei M,Profire BS,Tauser GR,Lupascu D,Profire L .2025 .A State-of-the-Art Review on Recent Biomedical Application of Polysaccharide-Based Niosomes as Drug Delivery Systems. , 17(11) : 1566.
Teron C,Bhuyan A,Saikia P,Dutta SR,Gogoi H,Rongpi S .2024 .A comprehensive review on niosomes in drug delivery and recent advancements. J of Drug Deliv and Therap, 14(6) : 262-273.
Topalian SL,Hodi FS,Brahmer JR .2012 .Safety, activity, and immune correlates of antiPD-1 antibody in cancer. New England J of Med, 366(26) : 2443-2454.
Uchegbu IF,Vyas SP .1998 .Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm., 172(1-2) : 33-70.
Van der Zanden SY,Qiao X,Neefjes J .2021 .New insights into the activities and toxicities of the old anticancer drug doxorubicin. The FEBS J., 288(21) : 6095-6111.
Von Arx C,De Placido P,Caltavituro A,Di Rienzo R,Buonaiuto R,De Laurentiis M,Del Mastro L .2023 .The evolving therapeutic landscape of trastuzumab-drug conjugates: Future perspectives beyond HER2-positive breast cancer. Cancer Treatment Rev., 113 : 102500.
Zaer M,Moeinzadeh A,Abolhassani H,Rostami N,Tavakkoli Yaraki M,Seyedi SA,Nabipoorashrafi SA,Bashiri Z,Moeinabadi-Bidgoli K,Moradbeygi F .2023 .Doxorubicin-loaded niosomes functionalized with gelatin and alginate as pHresponsive drug delivery system: A 3D printing approach. Intl J Biol Macromol., 253 : 126808.
Zhao X,Xie N,Zhang H,Zhou W,Ding J .2023 .Bacterial Drug Delivery Systems for Cancer Therapy: "Why" and "How". Pharmaceutics, 15 : 2214.
Zhen A,Zhang M,Liu F,Peng Q .2024 .Research progress of surface-active ionic liquids for drug delivery. J of Mol Liquids, 400 : 124546.
Zhu Y,Kuo MT,Jansen B .2008 ."Doxorubicin and its clinical applications." Cancer Res. , 68(10) : 429-434.
0

Citations

0

Downloads

11

Views